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Dogs are the main reservoir of Leishmania infantum and in 
some countries have been regularly culled as part of govern-
ment policy to control visceral leishmaniasis. At the 13th Sym-
posium of the Companion Vector-Borne Diseases World Fo-
rum in Windsor, UK, March 19–22, 2018, we consolidated a 
consensus statement regarding the usefulness of dog culling 
as a means of controlling visceral leishmaniasis. The state-
ment highlighted the futility of culling infected dogs, whether 
healthy or sick, as a measure to control the domestic reservoir 
of L. infantum and reduce the risk for visceral leishmaniasis.
Visceral leishmaniasis (VL), caused by Leishmania donovani in Asia and Africa and by L. infantum in 
the Mediterranean Basin, the Middle East, Central Asia, 
South America, and Central America, is a life-threatening 
disease that affects ≈200,000–400,000 persons annually 
and causes an estimated ≈20,000–40,000 deaths per year 
(1,2). Although an increasing number of other mammalian 
hosts, including infected humans, have served as effective 
reservoirs by infecting phlebotomine sand fly vectors, dogs 
remain a pivotal indirect source in many situations where 
the transmission cycle of L. infantum occurs (3,4).
Over the years, millions of dogs have been killed as 
part of government policies to control human VL caused 
by L. infantum, also known as zoonotic VL (5). The na-
tional public health policies of Central Asian, Caucasian, 
and some Balkan countries still recommend culling any 
L. infantum–positive dog (1). In rural areas of China, the 
Maghreb countries (North Africa), and parts of the Middle 
East, dog culling remains common practice (1), although 
medical therapy is usually allowed for dogs that are owned. 
In Central and South America, dog culling has been rec-
ommended and practiced in several countries, including 
Argentina, Brazil, Colombia, Uruguay, and Venezuela (1). 
Nonetheless, this practice has been replaced by more effec-
tive approaches, even in countries like Brazil, where thou-
sands of dogs used to be culled every year (5).
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The Companion Vector-Borne Diseases (CVBD) 
World Forum is a group of scientists working on canine 
and feline vectorborne diseases (6). This group contributes 
to an ongoing discussion and update on vectorborne dis-
eases from around the world and their effects on dogs, cats, 
and humans. Because the topic of canine leishmaniasis is 
of global importance and thus frequently discussed, a con-
sensus was reached that we should be more proactive in our 
position toward controlling this disease. At the 13th Sym-
posium of the CVBD World Forum, held in Windsor, UK, 
during March 19–22, 2018, we discussed the control of ca-
nine leishmaniasis caused by L. infantum in the context of 
One Health and consolidated a consensus statement about 
the usefulness of dog culling as a means of controlling VL. 
This statement targets areas where VL caused by L. infan-
tum is endemic and dog culling has been a common prac-
tice. We present this consensus statement and highlight the 
futility of culling infected dogs, whether clinically healthy 
or sick, as a measure to control the domestic reservoir of L. 
infantum and reduce the risk for VL in humans.
Scientific Reasons Why Dog Culling  
Is Unacceptable
In areas of Asia (e.g., China) where government regimes 
have promoted massive culling of all dogs (regardless of 
seropositive status), in association with widespread use of 
DDT for vector control (7), the disease incidence declined 
for many years. However, whether this was an effect of dog 
elimination, vector control, or both is difficult to say (5,7). In 
fact, during the past 20 years, a mass of scientific evidence 
has accumulated from around the world and under different 
ecologic scenarios that demonstrates the failure of dog cull-
ing as a control strategy, particularly in Brazil (5,7). A dog 
culling strategy is not supportable for several reasons.
First, no reliable body of scientific evidence supports 
the effectiveness of dog culling as a means of reducing 
the incidence of VL (8,9). Second, alternative reservoir 
hosts may play a role in maintaining the life cycle of L. 
infantum (3,4) and must be taken into consideration when 
an integrated control strategy is formulated. Third, culled 
dogs are rapidly replaced with young dogs that are often 
more susceptible to primary infection (10). Fourth, sero-
logic diagnostic tools often used for screening dogs as part 
of a culling program have limitations in terms of sensi-
tivity and specificity (e.g., cross-reactivity where other 
Leishmania spp. or trypanosomatids occur) (11,12). Fifth, 
dog culling is not a cost-effective, valid alternative from 
a socioeconomic perspective (e.g., effect of dog removal 
on their owners and drugs for euthanasia) to government 
institutions (7), particularly in developing countries, that 
promises a long-term solution to the problem. Finally, 
effective control of L. infantum transmission requires in-
tegrated approaches focusing not only on the dog as an 
indirect source, but also the parasite and, importantly, the 
sand fly vector (13). Thus, the use of dog culling as a strat-
egy to reduce the incidence of VL in humans cannot be 
justified and should no longer be used.
Alternative and More Effective Solutions for Better 
Control of Canine Leishmaniasis
A plethora of scientific evidence demonstrates that the 
regular use of topical repellent insecticides is highly ef-
fective in preventing phlebotomine sand fly bites (13–15) 
and, therefore, L. infantum transmission (16,17). The con-
stant use of repellent insecticides not only protects the 
dogs from sand flies infected on other hosts (and thus from 
becoming infected and acting as sources of infection) but 
also enables a reduction of these vectors in the vicinity of 
humans, potentially resulting in a reduction of human in-
fections and clinical VL incidence (18,19). Vaccines (i.e., 
Leish-Tec, Ceva Saúde Animal Ltda, https://www.
ceva.com.br/Produtos/Lista-de-Produtos/LEISH-TEC; 
CaniLeish, Virbac Schweiz AG, https://www.virbac.ch/
de/kleintiere-produkte/impfstoffe/canileish; and LetiFend, 
Laboratorios LETI, Lda., https://saludanimal.leti.com/
en/letifend-vaccine-against-canine-leishmaniasis_3944) 
are also available in some countries for reducing the risk 
for appearance of clinical signs and disease progression 
in infected dogs (15,20). Chemotherapy (e.g., allopurinol 
plus meglumine antimoniate or allopurinol plus miltefos-
ine) and immune therapy (e.g., domperidone, and dietary 
nucleotides plus active hexose correlated compound) also 
may reduce the infectiousness of treated dogs, leading to a 
decrease of infected phlebotomine sand flies under experi-
mental conditions (15,21–25).
Our Consensus Advice and Practical Recommendations
All veterinarians take an oath, an example of which is: “I 
solemnly swear to use my scientific knowledge and skills 
for the benefit of society through the protection of animal 
health and welfare, the prevention and relief of animal 
suffering, the conservation of animal resources, the pro-
motion of public health, and the advancement of medical 
knowledge” (https://www.avma.org/KB/Policies/Pages/
veterinarians-oath.aspx). For the control of VL by L. in-
fantum, scientific data clearly align closely with the senti-
ments expressed by all veterinarians in adhering to their 
oath, certain in the knowledge that preventive methods 
should be used, rather than the practice of dog culling, 
which we believe to be unethical and unjustifiable from a 
scientific viewpoint.
Using the basis of a One Health approach toward the 
prevention of zoonotic Leishmania infection in animals and 
humans, the members of the CVBD World Forum advocate 
the following recommendations concerning L. infantum in-
fection in companion animals:
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1.  Companion animals should be protected from phle-
botomine sand fly bites to prevent either leishmanial 
primary infection or spread from already infected 
dogs. Additional control measures, including envi-
ronmental vector control, vaccination, and prophylac-
tic medications (14,15,26), may also be used where 
available.
2.  Dog culling in areas where VL is endemic should be 
replaced with alternative nonterminal measures that 
can prevent infection in dogs.
The members of the CVBD World Forum recommend 
the following measures to reduce the risk for L. infantum 
infection in dogs and in humans:
1.  Promote phlebotomine sand fly bite prevention to re-
duce the risk for L. infantum infection in noninfected 
dogs and its spread from already infected dogs.
2.  Improve the general health and nutritional status of 
dogs.
3.  Implement latest concepts regarding the clinical man-
agement of canine leishmaniasis, including approach-
es to diagnosis and treatment.
4.  Improve environmental and housing conditions to en-
hance phlebotomine sand fly control and reduce the 
exposure of humans to the vectors.
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